Please Wait
Applying Filters...
menu
    • menu
    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Nicotinamide Riboside

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 871Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Niagen Bioscience Acquires Full Ownership Of Vital NAD+ Patents
    Niagen Bioscience Acquires Full Ownership Of Vital NAD+ Patents

    24 Dec 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/niagen-bioscience-secures-full-ownership-of-key-nad-patents-in-major-ip-move-18667

    INDPHARMAPOST
    24 Dec 2025
    Share Share
    Niagen Bio Acquires Patent Portfolio From Queen's University
    Niagen Bio Acquires Patent Portfolio From Queen's University

    22 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-22/niagen-bioscience-acquires-existing-core-nicotinamide-riboside-nr-patent-portfolio-from-queen-s-un

    PHARMIWEB
    22 Dec 2025
    Share Share
    Niagen Bioscience Introduces Tru Niagen Beauty
    Niagen Bioscience Introduces Tru Niagen Beauty

    13 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251113779285/en/Niagen-Bioscience-Launches-Tru-Niagen-Beauty-The-First-NAD-Skincare-Supplement-in-the-U.S.-Featuring-Niagen-Patented-Nicotinamide-Riboside

    BUSINESSWIRE
    13 Nov 2025
    Share Share
    Niagen Bioscience to Report Q1 2025 Results on May 7, 2025
    Niagen Bioscience to Report Q1 2025 Results on May 7, 2025

    28 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250425638128/en/Niagen-Bioscience-to-Report-First-Quarter-2025-Financial-Results-on-Wednesday-May-7-2025

    BUSINESSWIRE
    28 Apr 2025
    Share Share
    Niagen Gets US Patent For Nicotinamide Riboside Salt Forms
    Niagen Gets US Patent For Nicotinamide Riboside Salt Forms

    20 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250320005293/en/Niagen-Bioscience-Secures-U.S.-Patent-for-the-Composition-of-Matter-for-Nicotinamide-Riboside-NR-Salt-Forms

    BUSINESSWIRE
    20 Mar 2025
    Share Share
    Niagen® improves mobility in PAD per Phase II study.
    Niagen® improves mobility in PAD per Phase II study.

    24 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240624062781/en

    BUSINESSWIRE
    24 Jun 2024
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.